cdr

Hot Keywords
Drug Resistance Mechanisms Epigenetic Resistance in Cancer Therapy Biomarkers Pharmacogenetics of Cancer Liquid Biopsy Targeted Cancer Therapy Non-coding RNAs Kinase Inhibitors ABC Transporters

Top

Acknowledgment to Reviewers

Published on: 17 Jan 2019 Viewed: 1161
We would like to sincerely thank each and every reviewer who dedicated his or her time and expertise to reviewing manuscripts for Cancer Drug Resistance (CDR). In the review process, at least two experts contribute comments to each paper published in CDR. Without their help, CDR would not be as fast-growing as it is today. Thus, the journal of Cancer Drug Resistance acknowledges with particular gratitude the following reviewers who gave freely their support during the period of March-December, 2018.
  • Amstutz, Ursula
  • Ahmad, Aamir
  • Balboni, Beatrice
  • Ciriza, Jesús
  • Cloos, Jacqueline
  • Del Re, Marzia
  • El Hassouni, Btissame
  • Fenton, Tim
  • Fiandalo, Michael
  • Firuzi, Omid
  • Gan, Boyi
  • Garajová, Ingrid
  • Garrett, Michelle
  • Giovannetti, Elisa
  • Gong, Li
  • Griffiths, Elizabeth
  • Huang, Shiliang
  • Huisman, M.C.
  • Hussain, Suleman
  • Jansen, Gerrit
  • Jiang, Zhao
  • Joerger, Markus
  • Kwok, Hang Fai
  • Link, Wolfgang
  • Marchesi, Federica
  • Matsuura, Yoshiyuki
  • Michaelis, Martin
  • Mini, Enrico
  • Nobili, Stefania
  • Nowak-Sliwinska, Patrycja
  • Pasternak, Amy
  • Perego, Paola
  • Phillips, Roger M
  • Pore, Milind
  • Rodriguez, Jose Antonio
  • Rosière, Rémi
  • Wass, Mark
  • Zaffaroni, Nadia
© 2016-2021 OAE Publishing Inc., except certain content provided by third parties